Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.

The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland - 1 Oct 2009

Liau S S, Whang E

Abstract excerpt

High mobility group A1 (HMGA1) proteins are architectural transcriptional factors that are over-expressed in a wide range of human malignancies. Recently published evidence suggests HMGA1 is a promising candidate biomarker and therapeutic target in pancreatic cancer. This review summarises data implicating HMGA1 as an important mediator of progression in human cancer and in pancreatic cancer.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Adenocarcinoma
Share to Biomarkers, Tumor
Share to Gene Expression Regulation, Neoplastic

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genotype

Share to Pancreatic Neoplasms

Share to Phenotype

Source

Open in PubMed Open full text

Identifiers

PMID: 19848064
DOI: 10.1016/s1479-666x(09)80008-5
PMCID: PMC3064443

Genes

HMGA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

High mobility group A: a novel biomarker and therapeutic target in pancreatic adenocarcinoma.PMID 19848064Read ↗

WITHDRAWN: Exogenous HMGB1 promotes pancreatic cancer progression by supporting the crosstalk between tumor and myeloid-derived suppressor cellSemantic proximity Read ↗

HMGA1 expression levels are elevated in pancreatic intraepithelial neoplasia cells in the Ptf1a-Cre; LSL-KrasG12D transgenic mouse model of pancreatic cancer.Semantic proximity Read ↗

The dual role and therapeutic potential of high-mobility group box 1 in cancerSemantic proximity Read ↗

Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancerSemantic proximity Read ↗

HMG Box-Containing Protein 1 (HBP1) Protects Against Pancreatic Injury in Acute Pancreatitis but Promotes Neoplastic ProgressionSemantic proximity Read ↗

HMGA1 in cancer: Cancer classification by locationSemantic proximity Read ↗

Pancreatic duct cell carcinomas express high levels of high mobility group I(Y) proteins.Semantic proximity Read ↗

Role of HMGB1 and its associated signaling pathways in human malignanciesSemantic proximity Read ↗

Multiple functions of HMGB1 in cancerSemantic proximity Read ↗

Masquerader: High Mobility Group Box-1 and CancerSemantic proximity Read ↗

Contributing Role of High Mobility Group Box 1 Signaling in Oral Cancer Development and TherapySemantic proximity Read ↗

High mobility group box 1 (HMGB1): a pivotal regulator of hematopoietic malignanciesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.